Simson Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.25 Cr
as on 24-10-2024
- Revenue 28.21%
(FY 2023)
- Profit 27.30%
(FY 2023)
- Ebitda 17.30%
(FY 2023)
- Net Worth 46.93%
(FY 2023)
- Total Assets 43.30%
(FY 2023)
About Simson Pharma
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.25 Cr.
Manga Penchala, Satyanarayana Penchala, and Bhavika Penchala serve as directors at the Company.
- CIN/LLPIN
U24230MH2018PLC308280
- Company No.
308280
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Simson Pharma Limited offer?
Simson Pharma Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Chemical Intermediates, Pharma Ingredients & Raw Materials, API Intermediate, API Impurities, API (Active Pharmaceutical Ingredients), Carvedilol Intermediates, Cardiac Drugs, Gemfibrozil Tablet, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Simson Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Penchala  | Managing Director | 19-Apr-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manga Penchala | Director | 19-Apr-2018 | Current |
| Bhavika Penchala | Director | 19-Apr-2018 | Current |
Financial Performance of Simson Pharma.
Simson Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.21% increase. The company also saw a substantial improvement in profitability, with a 27.3% increase in profit. The company's net worth Soared by an impressive increase of 46.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Simson Pharma?
In 2023, Simson Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amertha Life Sciences LlpActive 9 years 9 monthsManga Penchala and Satyanarayana Penchala are mutual person
- Wish Laboratories LlpActive 9 years 5 months
Manga Penchala and Satyanarayana Penchala are mutual person
- Simsol Medipharma LlpActive 4 years 2 months
Manga Penchala, Satyanarayana Penchala and 1 more are mutual person
- Simson Life Sciences Private LimitedActive 13 years 3 days
Manga Penchala and Satyanarayana Penchala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 13 Oct 2023 | ₹1.25 Cr | Open |
How Many Employees Work at Simson Pharma?
Simson Pharma has a workforce of 218 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Simson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simson Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
